Important Facts About CYRAMZA® (sigh-RAM-zuh). It is also known as ramucirumab.
CYRAMZA is a prescription medicine used to treat certain types of cancer. It is given by intravenous (IV) infusion. An IV infusion is when a needle is placed into your vein and a medicine is given slowly. CYRAMZA is prescribed in these ways:
It is not known if CYRAMZA is safe and effective in children.
CYRAMZA may cause serious side effects, including:
Tell your doctor right away if you have:
The most common side effects of CYRAMZA when given by itself include:
The most common serious side effects of CYRAMZA when given by itself include:
Some people needed to have extra red blood cells put into their blood.
The most common side effects of CYRAMZA when given with certain chemotherapy medicines include:
The most common serious side effects of CYRAMZA when given with certain chemotherapy medicines include:
Some people needed treatment to increase their white blood cell counts.
These are not all the possible side effects of CYRAMZA. Tell your doctor if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.
Before you receive CYRAMZA, tell your doctor if you:
Also tell your doctor about all the medicines and supplements you take, whether they have been prescribed for you or you buy them without a prescription.
For more information, call 1-800-545-5979 or go to CYRAMZA.com.
This summary provides basic information about CYRAMZA. It does not include everything known about this medicine. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other healthcare provider about CYRAMZA and how it is given. Your doctor is the best person to help you decide if CYRAMZA is right for you.
CYRAMZA® is a registered trademark owned or licensed by Eli Lilly & Company, its subsidiaries, or affiliates.
Please see the full Prescribing Information for CYRAMZA.
RB CON BS 10MAY2019